Pneumococcal Bacteremia and Cryptococcal Meningitis Dual Infection in a Patient With Multiple Myeloma

Abdul Raheem1, Balram Rathish2, Deepak Charles3

  • 1Internal Medicine, Aster Medcity, Kochi, IND.

Cureus
|June 22, 2021
PubMed

Insights

Multiple myeloma patients face high infection risks due to disease and chemotherapy. A rare dual infection of pneumococcal bacteremia and cryptococcal meningitis in a myeloma patient had a favorable outcome, emphasizing adult vaccination importance.

Area of Science:

  • Infectious Diseases
  • Hematology
  • Immunology

Background:

  • Multiple myeloma (MM) patients exhibit increased susceptibility to infections, a major cause of morbidity and mortality.
  • Impaired immune function in MM arises from the disease itself and cytotoxic chemotherapy regimens.
  • Prophylactic measures, including vaccination, are crucial for managing infectious complications in immunocompromised patients.

Observation:

  • A rare case of concurrent pneumococcal bacteremia and cryptococcal meningitis is presented in a patient with multiple myeloma.
  • The patient presented with symptoms indicative of a severe dual bloodstream and central nervous system infection.
  • Despite the severity, the patient received appropriate antimicrobial therapy and supportive care.

Findings:

  • Successful treatment and favorable clinical outcome were achieved for the dual infection in the multiple myeloma patient.
  • Prompt diagnosis and targeted antimicrobial therapy were key to managing the complex infectious scenario.
  • The case underscores the potential for severe, yet treatable, opportunistic infections in MM patients.

Implications:

  • This case highlights the critical need for vigilance regarding opportunistic infections in multiple myeloma patients.
  • It emphasizes the significant benefit of adult vaccination strategies in immunocompromised individuals, particularly those with hematologic malignancies.
  • Early recognition and management of dual infections can lead to positive patient outcomes, improving quality of life and survival rates.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
447
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
440
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
546
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
251
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
751
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
534